tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Bio-Techne Corp

TECH
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
71.600USD
-0.170-0.24%
์ข…๊ฐ€ย 07-24 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
11.16B์‹œ๊ฐ€์ด์•ก
101.45P/E TTM

TradingKey Bio-Techne Corp ์ฃผ์‹ ์ ์ˆ˜

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: 2026-07-24

์ฃผ์š” ์ธ์‚ฌ์ดํŠธ

Bio-Techne Corp์˜ ํŽ€๋”๋ฉ˜ํ„ธ์€ ๋น„๊ต์  ์•„์ฃผ ๊ฑด์ „ํ•œ ์ƒํƒœ์ด๋ฉฐ, ์„ฑ์žฅ ์ž ์žฌ๋ ฅ์€ ๋†’์Šต๋‹ˆ๋‹ค.๊ธฐ์—…์˜ ๋ฐธ๋ฅ˜์—์ด์…˜์€ ์ ์ •ํ•˜๊ฒŒ ํ‰๊ฐ€๋œ ๊ฒƒ์œผ๋กœ ๊ฐ„์ฃผ๋˜๋ฉฐ, ์ƒ๋ช…๊ณตํ•™ ๋ฐ ์˜๋ฃŒ ์—ฐ๊ตฌ ์‚ฐ์—…์—์„œ 386๊ฐœ ์ค‘ 36์œ„ ๋žญํ‚น.๊ธฐ๊ด€ ๋ณด์œ  ๋น„์œจ์€ ๋งค์šฐ ๋†’์€.์ง€๋‚œ ํ•œ ๋‹ฌ ๋™์•ˆ ์—ฌ๋Ÿฌ ์• ๋„๋ฆฌ์ŠคํŠธ๊ฐ€ ํ•ด๋‹น ๊ธฐ์—…์„ ๋ณด์œ (์œผ)๋กœ ํ‰๊ฐ€ํ–ˆ์œผ๋ฉฐ, ์ตœ๊ณ  ๋ชฉํ‘œ ๊ฐ€๊ฒฉ์€ 70.30์ž…๋‹ˆ๋‹ค.์ค‘๊ธฐ์ ์œผ๋กœ ์ฃผ๊ฐ€๋Š” ์ƒ์Šน ์ถ”์„ธ์ผ ๊ฒƒ์œผ๋กœ ์˜ˆ์ƒ๋ฉ๋‹ˆ๋‹ค.์ง€๋‚œ ํ•œ ๋‹ฌ๊ฐ„ ์ฃผ์‹ ์‹œ์žฅ์—์„œ ํ‰๋ฒ”ํ•œ ์„ฑ๊ณผ๋ฅผ ๊ฑฐ๋‘์—ˆ์ง€๋งŒ, ๊ธฐ์—…์˜ ํŽ€๋”๋ฉ˜ํ„ธ์€ ํƒ„ํƒ„ํ•ฉ๋‹ˆ๋‹ค.์ฃผ๊ฐ€๋Š” ์ง€์ง€์„ ๊ณผ ์ €ํ•ญ์„  ์‚ฌ์ด์—์„œ ํšก๋ณดํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ๋ฒ”์œ„ ๋งค๋งค ๊ธฐ๋ฐ˜์˜ ์Šค์œ™ ํŠธ๋ ˆ์ด๋”ฉ์— ์ ํ•ฉํ•œ ์ƒํ™ฉ์ž…๋‹ˆ๋‹ค.

Bio-Techne Corp ์ ์ˆ˜๎˜ฐ๎˜ฐ

๊ด€๋ จ ์ •๋ณด

์‚ฐ์—… ์ˆœ์œ„
36 / 386
์ „์ฒด ์ˆœ์œ„
93 / 4279
์‚ฐ์—…
์ƒ๋ช…๊ณตํ•™ ๋ฐ ์˜๋ฃŒ ์—ฐ๊ตฌ

์ €ํ•ญ์„  & ์ง€์ง€์„ 

๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

๋ ˆ์ด๋” ์ฐจํŠธ

ํ˜„์žฌ ๊ฐ€๊ฒฉ
๊ณผ๊ฑฐ

๋ฏธ๋””์–ด ๋ณด๋„

์ตœ๊ทผ 24 ์‹œ๊ฐ„
๋ณด๋„ ์ˆ˜์ค€

๋งค์šฐ ๋‚ฎ์€
๋งค์šฐ ๋†’์€
๊ธ์ •

Bio-Techne Corp ์ฃผ์š” ๋‚ด์šฉ

๊ฐ•์ ์œ„ํ—˜ ์š”์†Œ
Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Companyโ€™s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, advanced tissue-based in-situ hybridization assays and instrumentation for spatial genomic and tissue biopsy analysis and genetic and oncology kits for research and clinical applications. Its product portfolio and application enable scientific investigations into biological processes and molecular diagnostics and progression of specific diseases.
๋†’์€ ๋ฐฐ๋‹น๊ธˆ
ํšŒ์‚ฌ๋Š” ๋†’์€ ๋ฐฐ๋‹น๊ธˆ์„ ์ง€๊ธ‰ํ•˜๋Š” ํšŒ์‚ฌ๋กœ, ์ตœ์‹  ๋ฐฐ๋‹น๊ธˆ ์ง€๊ธ‰ ๋น„์œจ์€ 68.69%์ž…๋‹ˆ๋‹ค.
์•ˆ์ •์ ์ธ ๋ฐฐ๋‹น๊ธˆ
ํšŒ์‚ฌ๋Š” ์ง€๋‚œ 5๋…„ ๋™์•ˆ ์ •๊ธฐ์ ์œผ๋กœ ๋ฐฐ๋‹น๊ธˆ์„ ์ง€๊ธ‰ํ•˜์˜€์œผ๋ฉฐ, ์ตœ์‹  ๋ฐฐ๋‹น๊ธˆ ์ง€๊ธ‰ ๋น„์œจ์€ 68.69%์ž…๋‹ˆ๋‹ค.
๊ณผ๋Œ€ ํ‰๊ฐ€๋œ
ํšŒ์‚ฌ์˜ ์ตœ์‹  PE์€ 101.45๋กœ, ์ตœ๊ทผ 3๋…„ ๊ธฐ์ค€ ๋†’์€ ๋ฐฑ๋ถ„์œ„ ๋ฒ”์œ„์— ์†ํ•ฉ๋‹ˆ๋‹ค.
๊ธฐ๊ด€ ๋งค์ˆ˜
์ตœ์‹  ๊ธฐ๊ด€ ๋ณด์œ  ์ฃผ์‹ ์ˆ˜๋Š” 178.19M์ฃผ์ด๋ฉฐ, ์ „ ๋ถ„๊ธฐ ๋Œ€๋น„ 0.00% ์ฆ๊ฐ€ํ–ˆ์Šต๋‹ˆ๋‹ค.
๋ฆฌ ์—์ธ์Šฌ๋ฆฌ๊ฐ€ ๋ณด์œ 
์Šคํƒ€ ํˆฌ์ž์ž ๋ฆฌ ์—์ธ์Šฌ๋ฆฌ์ด(๊ฐ€) ์ด ์ฃผ์‹ 5.14M์ฃผ๋ฅผ ๋ณด์œ ํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.
์‹œ์žฅ ํ™œ๋™ ์ฆ๊ฐ€
ํšŒ์‚ฌ๋Š” ํˆฌ์ž์ž๋“ค์˜ ๊ด€์‹ฌ์ด ๋†’์•„์ ธ, ์ตœ๊ทผ 20์ผ๊ฐ„ ํšŒ์ „์œจ์ด 2.68์ž…๋‹ˆ๋‹ค.

๋ถ„์„๊ฐ€ ๋ชฉํ‘œ๊ฐ€

17 ๋ช…์˜ ๋ถ„์„๊ฐ€๋ฅผ ๊ธฐ์ค€์œผ๋กœ
์œ ์ง€
ํ˜„์žฌ ๋“ฑ๊ธ‰
70.301
๋ชฉํ‘œ ๊ฐ€๊ฒฉ
-2.05%
์ƒ์Šน ์—ฌ๋ ฅ

์œ ์‚ฌ ์ข…๋ชฉ

์ƒ๋ช…๊ณตํ•™ ๋ฐ ์˜๋ฃŒ ์—ฐ๊ตฌ
๎™
Bio-Techne Corp
Bio-Techne Corp
TECH
7.07 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
Ionis Pharmaceuticals Inc
Ionis Pharmaceuticals Inc
IONS
8.09 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
IQVIA Holdings Inc
IQVIA Holdings Inc
IQV
7.88 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
CareDx Inc
CareDx Inc
CDNA
7.83 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
Cue Biopharma Inc
Cue Biopharma Inc
CUE
7.77 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
Maze Therapeutics Inc
Maze Therapeutics Inc
MAZE
7.75 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
๋” ๋ณด๊ธฐ

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

TradingKey๋Š” ์–ด๋–ค ๋ฐฉ์‹์œผ๋กœ Bio-Techne Corp์˜ ์ฃผ์‹ ์ ์ˆ˜๋ฅผ ์ƒ์„ฑํ•˜๋‚˜์š”?

๎™Œ
TradingKey ์ฃผ์‹ ์ ์ˆ˜๋Š” 100๊ฐœ ์ด์ƒ์˜ ๊ธฐ์ดˆ ๋ฐ์ดํ„ฐ ํฌ์ธํŠธ์—์„œ ๋„์ถœ๋œ 34๊ฐœ์˜ ์ง€ํ‘œ๋ฅผ ๊ธฐ๋ฐ˜์œผ๋กœ Bio-Techne Corp์— ๋Œ€ํ•œ ์ข…ํ•ฉ ํ‰๊ฐ€๋ฅผ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค.
์ด ์ง€ํ‘œ๋“ค์€ ์žฌ๋ฌด ๊ฑด์ „์„ฑ, ํšŒ์‚ฌ ๊ฐœ์š”, ์ˆ˜์ต ์˜ˆ์ƒ, ๊ฐ€๊ฒฉ ๋ชจ๋ฉ˜ํ…€, ๊ธฐ๊ด€ ์‹ ๋ขฐ, ๋ฆฌ์Šคํฌ ํ‰๊ฐ€์˜ ์—ฌ์„ฏ ๊ฐ€์ง€ ํ•ต์‹ฌ ์ฐจ์›์œผ๋กœ ๋ถ„๋ฅ˜๋˜๋ฉฐ, ์ด๋“ค์€ ํ•จ๊ป˜ Bio-Techne Corp์˜ ์„ฑ๊ณผ์™€ ์ „๋ง์— ๋Œ€ํ•œ ์ฒ ์ €ํ•œ ๋ถ„์„์„ ํˆฌ์ž์ž์—๊ฒŒ ์ œ์‹œํ•ฉ๋‹ˆ๋‹ค.

Bio-Techne Corp์˜ ์žฌ๋ฌด ๊ฑด์ „์„ฑ ์ ์ˆ˜๋Š” ์–ด๋–ป๊ฒŒ ์ƒ์„ฑ๋˜๋‚˜์š”?

๎™Œ
Bio-Techne Corp์˜ ์žฌ๋ฌด ๊ฑด์ „์„ฑ ์ ์ˆ˜๋ฅผ ์‚ฐ์ถœํ•˜๊ธฐ ์œ„ํ•ด์„œ๋Š” ์žฌ๋ฌด ํŽ€๋”๋ฉ˜ํ„ธ, ์ˆ˜์ต ํ’ˆ์งˆ, ์šด์˜ ํšจ์œจ์„ฑ, ์„ฑ์žฅ ์ž ์žฌ๋ ฅ, ์ฃผ์ฃผ ์ˆ˜์ต ๋“ฑ์˜ ํ•ต์‹ฌ ์ฐจ์›์„ ๊ธฐ๋ฐ˜์œผ๋กœ ๋‹ค์–‘ํ•œ ์ฃผ์š” ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ๋ถ„์„ํ•ฉ๋‹ˆ๋‹ค.
์ด๋Ÿฌํ•œ ์ข…ํ•ฉ ๋ฐ์ดํ„ฐ๋ฅผ ํ†ตํ•ฉํ•˜์—ฌ ๋„์ถœ๋œ ์žฌ๋ฌด ๊ฑด์ „์„ฑ ์ ์ˆ˜๋Š” Bio-Techne Corp์˜ ์ „๋ฐ˜์ ์ธ ์•ˆ์ •์„ฑ, ์šด์˜ ํšจ์œจ์„ฑ, ์„ฑ์žฅ ์ž ์žฌ๋ ฅ๋ฟ๋งŒ ์•„๋‹ˆ๋ผ ์ฃผ์ฃผ์—๊ฒŒ ์ „๋‹ฌ๋˜๋Š” ์ˆ˜์ต๋„ ๋ฐ˜์˜ํ•ฉ๋‹ˆ๋‹ค. ์ด ์ ์ˆ˜๋Š” ํˆฌ์ž์ž ๋ฐ ๊ธฐํƒ€ ์ดํ•ด๊ด€๊ณ„์ž๊ฐ€ ํ•ฉ๋ฆฌ์ ์ธ ์˜์‚ฌ๊ฒฐ์ •์„ ๋‚ด๋ฆด ์ˆ˜ ์žˆ๋„๋ก ์ง€์›ํ•˜๋ฉฐ, ์ ์ˆ˜๊ฐ€ ๋†’์„์ˆ˜๋ก Bio-Techne Corp์˜ ์žฌ๋ฌด ๊ฑด์ „์„ฑ์ด ์šฐ์ˆ˜ํ•จ์„ ์˜๋ฏธํ•ฉ๋‹ˆ๋‹ค.

Bio-Techne Corp์˜ ๊ธฐ์—… ๊ฐ€์น˜ ์ ์ˆ˜๋Š” ์–ด๋–ป๊ฒŒ ์ƒ์„ฑ๋˜๋‚˜์š”?

๎™Œ
Bio-Techne Corp์˜ ๊ธฐ์—… ๊ฐ€์น˜ํ‰๊ฐ€ ์ ์ˆ˜๋ฅผ ์‚ฐ์ถœํ•˜๊ธฐ ์œ„ํ•ด์„œ๋Š” ์ฃผ๊ฐ€์ˆ˜์ต๋น„์œจ(P/E), ์ฃผ๊ฐ€์ˆœ์ž์‚ฐ๋น„์œจ(P/B), ์ฃผ๊ฐ€๋งค์ถœ๋น„์œจ(P/S), ์ฃผ๊ฐ€ํ˜„๊ธˆํ๋ฆ„๋น„์œจ(P/CF) ๋“ฑ ๋‹ค์–‘ํ•œ ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ์„ ์‚ฌ์šฉํ•ฉ๋‹ˆ๋‹ค. ์ด๋Ÿฌํ•œ ์ˆ˜์น˜๋Š” Bio-Techne Corp์˜ ์‹œ์žฅ ๊ฐ€์น˜๋ฅผ ์ˆ˜์ต, ์ž์‚ฐ, ๋งค์ถœ ๋ฐ ํ˜„๊ธˆ ํ๋ฆ„๊ณผ ๋น„๊ตํ•˜์—ฌ ๊ธฐ์—… ๊ฐ€์น˜๋ฅผ ํ‰๊ฐ€ํ•˜๊ธฐ ์œ„ํ•œ ํ•ต์‹ฌ ์ง€ํ‘œ ์—ญํ• ์„ ํ•ฉ๋‹ˆ๋‹ค.
์ด๋Ÿฌํ•œ ๋น„์œจ๋“ค์„ ์ข…ํ•ฉ์ ์œผ๋กœ ๋ถ„์„ํ•จ์œผ๋กœ์จ, ๊ฐ€์น˜ํ‰๊ฐ€ ์ ์ˆ˜๋Š” ์‹œ์žฅ์ด ํ˜„์žฌ Bio-Techne Corp์˜ ๊ฐ€์น˜๋ฅผ ์–ด๋–ป๊ฒŒ ์ธ์‹ํ•˜๊ณ  ์žˆ๋Š”์ง€๋ฟ๋งŒ ์•„๋‹ˆ๋ผ ๋ฏธ๋ž˜ ์ˆ˜์ต์„ฑ ๋ฐ ์„ฑ์žฅ ๊ฐ€๋Šฅ์„ฑ๊นŒ์ง€ ๋ฐ˜์˜ํ•˜์—ฌ ๋ณด๋‹ค ํ˜„๋ช…ํ•˜๊ฒŒ ํˆฌ์ž ๊ฒฐ์ •์„ ๋‚ด๋ฆด ์ˆ˜ ์žˆ๋„๋ก ์ง€์›ํ•ฉ๋‹ˆ๋‹ค. ์ ์ˆ˜๊ฐ€ ๋†’์„์ˆ˜๋ก Bio-Techne Corp์˜ ๊ณต์ •๊ฐ€์น˜์— ๊ฐ€๊น๋‹ค๋Š” ์ ์„ ์˜๋ฏธํ•ฉ๋‹ˆ๋‹ค.

Bio-Techne Corp์˜ ์ˆ˜์ต ์˜ˆ์ƒ ์ ์ˆ˜๋Š” ์–ด๋–ป๊ฒŒ ์ƒ์„ฑ๋˜๋‚˜์š”?

๎™Œ
Bio-Techne Corp์˜ ์ˆ˜์ต ์˜ˆ์ƒ ์ ์ˆ˜๋ฅผ ์‚ฐ์ถœํ•˜๊ธฐ ์œ„ํ•ด ๋ถ„์„๊ฐ€ ํ‰๊ฐ€, ์žฌ๋ฌด ์˜ˆ์ƒ, ์ง€์ง€์„  ๋ฐ ์ €ํ•ญ์„ , ๊ทธ๋ฆฌ๊ณ  ์—…๊ณ„ ๋น„๊ต์™€ ๊ฐ™์€ ๋‹ค์–‘ํ•œ ํ•ต์‹ฌ ์ง€ํ‘œ๋ฅผ ๊ณ ๋ คํ•ฉ๋‹ˆ๋‹ค:
ํ˜„์žฌ ๋“ฑ๊ธ‰๊ณผ ๋ชฉํ‘œ ๊ฐ€๊ฒฉ์€ ๋ถ„์„๊ฐ€์˜ ๊ธฐ๋Œ€๋ฅผ ์ง์ ‘ ๋ฐ˜์˜ํ•˜๋ฉฐ, ์ƒ์Šน ์—ฌ๋ ฅ์€ ํ•ด๋‹น ์ฃผ์‹์˜ ์„ฑ์žฅ ์ž ์žฌ๋ ฅ์— ๋Œ€ํ•œ ๋ถ„์„๊ฐ€๋“ค์˜ ๋ณด๊ธฐ๋ฅผ ๋‚˜ํƒ€๋ƒ…๋‹ˆ๋‹ค.
์ฃผ๋‹น์ˆœ์ด์ต(EPS), ์ˆ˜์ต, ์ˆœ์ด์ต, ์ด์ž ๋ฐ ์„ธ๊ธˆ ์ฐจ๊ฐ ์ „ ์ด์ต(EBIT)๊ณผ ๊ฐ™์€ ์žฌ๋ฌด ์ง€ํ‘œ๋Š” ์ˆ˜์ต์„ฑ์„ ํ‰๊ฐ€ํ•˜๋Š” ํ•ต์‹ฌ ์ฒ™๋„์ž…๋‹ˆ๋‹ค.
๋ชฉํ‘œ ๊ฐ€๊ฒฉ์˜ ๊ณ ๊ฐ€, ์ค‘๊ฐ„๊ฐ’, ์ €๊ฐ€ ๊ฐ€๊ฒฉ ๋ฒ”์œ„๋ฅผ ๋ถ„์„ํ•จ์œผ๋กœ์จ, ๊ฐ€๊ฒฉ ์ถ”์„ธ๋ฅผ ํŒŒ์•…ํ•˜๊ณ  ํ•ต์‹ฌ ์ง€์ง€์„  ๋ฐ ์ €ํ•ญ์„ ์„ ์‹๋ณ„ํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
์ด๋Ÿฌํ•œ ์ง€ํ‘œ๋ฅผ ๋™์ข… ์—…๊ณ„์™€ ๋น„๊ตํ•จ์œผ๋กœ์จ ์ฃผ์‹์˜ ์„ฑ๊ณผ์— ๋Œ€ํ•œ ๋งฅ๋ฝ์„ ์ œ๊ณตํ•˜๊ณ  ๋ณด๋‹ค ํ˜„์‹ค์ ์ธ ์˜ˆ์ƒ ์„ค์ •์— ๋„์›€์ด ๋ฉ๋‹ˆ๋‹ค.
์ด๋Ÿฌํ•œ ์š”์†Œ๋“ค์€ ํ†ตํ•ฉ๋˜์–ด ์ฃผ์‹์˜ ์˜ˆ์ƒ ์žฌ๋ฌด ์‹ค์ ๊ณผ ์„ฑ์žฅ ์ž ์žฌ๋ ฅ์„ ์ •ํ™•ํ•˜๊ฒŒ ๋ฐ˜์˜ํ•˜๋Š” ์ข…ํ•ฉ์ ์ธ ์ˆ˜์ต ์˜ˆ์ƒ ์ ์ˆ˜๋ฅผ ๊ตฌ์„ฑํ•ฉ๋‹ˆ๋‹ค. ์ ์ˆ˜๊ฐ€ ๋†’์„์ˆ˜๋ก ๋ถ„์„๊ฐ€๋Š” Bio-Techne Corp์˜ ๋ฏธ๋ž˜ ์ „๋ง์„ ๋” ๋‚™๊ด€์ ์œผ๋กœ ๋ณด๊ณ  ์žˆ์Œ์„ ์‹œ์‚ฌํ•ฉ๋‹ˆ๋‹ค.

Bio-Techne Corp์˜ ๊ฐ€๊ฒฉ ๋ชจ๋ฉ˜ํ…€ ์ ์ˆ˜๋Š” ์–ด๋–ป๊ฒŒ ์ƒ์„ฑ๋˜๋‚˜์š”?

๎™Œ
Bio-Techne Corp์˜ ๊ฐ€๊ฒฉ ๋ชจ๋ฉ˜ํ…€ ์ ์ˆ˜๋ฅผ ์‚ฐ์ถœํ•˜๊ธฐ ์œ„ํ•ด์„œ๋Š” ์ง€์ง€์„  ๋ฐ ์ €ํ•ญ์„ ๊ณผ ๊ฑฐ๋ž˜๋Ÿ‰ ์ˆ˜์น˜๋ฅผ ํฌํ•จํ•œ ๋ชจ๋ฉ˜ํ…€ ์ง€ํ‘œ๋ฅผ ๋ถ„์„ํ•ฉ๋‹ˆ๋‹ค.
์ง€์ง€์„ ์€ ๋งค์ˆ˜ ์ˆ˜์š”๊ฐ€ ์ปค์„œ ๊ฐ€๊ฒฉ ํ•˜๋ฝ์„ ๋ฐฉ์–ดํ•  ์ˆ˜ ์žˆ๋Š” ๊ฐ€๊ฒฉ ์ˆ˜์ค€์„ ์˜๋ฏธํ•˜๋ฉฐ, ์ €ํ•ญ์„ ์€ ๋งค๋„ ์••๋ ฅ์ด ์ฃผ๊ฐ€ ์ƒ์Šน์„ ๋ฐฉํ•ดํ•  ์ˆ˜ ์žˆ๋Š” ๊ฐ€๊ฒฉ ์ˆ˜์ค€์„ ์˜๋ฏธํ•ฉ๋‹ˆ๋‹ค. ์ผ๋ฐ˜์ ์ธ ๊ฐ€๊ฒฉ ๊ฑฐ๋ž˜๋Ÿ‰๊ณผ ์ด ๊ฑฐ๋ž˜๋Ÿ‰์„ ํ•จ๊ป˜ ๋ถ„์„ํ•จ์œผ๋กœ์จ ์‹œ์žฅ์—์„œ์˜ ์ „๋ฐ˜์ ์ธ ํ™œ๋™์„ฑ๊ณผ ์œ ๋™์„ฑ์„ ํ‰๊ฐ€ํ•ฉ๋‹ˆ๋‹ค. ์ด๋Ÿฌํ•œ ์ง€ํ‘œ๋Š” ๊ฐ€๊ฒฉ ์ถ”์„ธ์™€ ์ž ์žฌ์ ์ธ ๋ณ€ํ™”๋ฅผ ์‹๋ณ„ํ•˜๋Š” ๋ฐ ๋„์›€์„ ์ฃผ์–ด ํ–ฅํ›„ ์ˆ˜์ต์„ ๋ณด๋‹ค ์ •ํ™•ํ•˜๊ฒŒ ์˜ˆ์ธกํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
์ด์™€ ๊ฐ™์€ ์ข…ํ•ฉ์ ์ธ ๋ถ„์„์€ ์‹œ์žฅ ์‹ฌ๋ฆฌ๋ฅผ ๋ฐ˜์˜ํ•˜๊ณ  Bio-Techne Corp์˜ ๊ฐ€๊ฒฉ์— ๋Œ€ํ•œ ํ•ฉ๋ฆฌ์ ์ธ ์˜ˆ์ƒ์„ ๊ฐ€๋Šฅํ•˜๊ฒŒ ํ•ฉ๋‹ˆ๋‹ค. ์ ์ˆ˜๊ฐ€ ๋†’์„์ˆ˜๋ก Bio-Techne Corp์˜ ๋‹จ๊ธฐ ๊ฐ€๊ฒฉ ์ถ”์„ธ๊ฐ€ ๋” ์•ˆ์ •์ ์ž„์„ ๋‚˜ํƒ€๋ƒ…๋‹ˆ๋‹ค.

Bio-Techne Corp์˜ ๊ธฐ๊ด€ ์‹ ๋ขฐ ์ ์ˆ˜๋Š” ์–ด๋–ป๊ฒŒ ์ƒ์„ฑ๋˜๋‚˜์š”?

๎™Œ
Bio-Techne Corp์˜ ๊ธฐ๊ด€ ์‹ ๋ขฐ๋„ ์ ์ˆ˜๋ฅผ ์‚ฐ์ถœํ•˜๊ธฐ ์œ„ํ•ด์„œ๋Š” ๊ธฐ๊ด€์ด ๋ณด์œ ํ•œ ์ฃผ์‹์˜ ๋น„์œจ๊ณผ ๋ณด์œ  ์ฃผ์‹ ์ˆ˜๋ฅผ ๋ถ„์„ํ•ฉ๋‹ˆ๋‹ค. ๊ธฐ๊ด€ ๋ณด์œ  ๋น„์œจ์ด ๋†’์„์ˆ˜๋ก ์ „๋ฌธ ํˆฌ์ž์ž๋“ค์˜ ์‹ ๋ขฐ๋„๊ฐ€ ๋†’๋‹ค๋Š” ์ ์„ ์˜๋ฏธํ•˜๋ฉฐ, Bio-Techne Corp์˜ ์ž ์žฌ๋ ฅ์— ๋Œ€ํ•œ ๊ฐ•์„ธ ์‹ ํ˜ธ๋กœ ํ•ด์„๋ฉ๋‹ˆ๋‹ค. ๊ธฐ๊ด€ ํˆฌ์ž์ž๋Š” ์ผ๋ฐ˜์ ์œผ๋กœ ์ฒ ์ €ํ•œ ๋ถ„์„์„ ์ˆ˜ํ–‰ํ•œ ์ดํ›„ ํˆฌ์ž ๊ฒฐ์ •์„ ๋‚ด๋ฆฌ๋ฏ€๋กœ ๊ธฐ๊ด€ ๋ณด์œ  ์ฃผ์‹ ์ˆ˜๋ฅผ ๋ถ„์„ํ•˜๋ฉด ํ•ด๋‹น ์ฃผ์‹์— ๋Œ€ํ•œ ๊ธฐ๊ด€์˜ ์˜์ง€์™€ ํƒœ๋„๋ฅผ ๋” ๊นŠ์ด ์ดํ•ดํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ๊ธฐ๊ด€ ์‹ ๋ขฐ๋„๋ฅผ ์ดํ•ดํ•˜๋ฉด ์ˆ˜์ต ์˜ˆ์ƒ์„ ๋ณด๋‹ค ์ •๊ตํ•˜๊ฒŒ ๋‹ค๋“ฌ๊ณ , ๊ธฐ์—…์˜ ํ–ฅํ›„ ์„ฑ๊ณผ ๋ฐ ์‹œ์žฅ ์•ˆ์ •์„ฑ์— ๋Œ€ํ•ด ๋” ์‹ ๋ขฐํ•  ์ˆ˜ ์žˆ๋Š” ์‹œ๊ฐ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ ์ˆ˜๊ฐ€ ๋†’์„์ˆ˜๋ก Bio-Techne Corp์— ๋Œ€ํ•œ ๊ธฐ๊ด€์˜ ์ง€์ง€๋„๊ฐ€ ๋” ๋†’๋‹ค๋Š” ๊ฒƒ์„ ์˜๋ฏธํ•ฉ๋‹ˆ๋‹ค.

Bio-Techne Corp์˜ ๋ฆฌ์Šคํฌ ๊ด€๋ฆฌ ์ ์ˆ˜๋Š” ์–ด๋–ป๊ฒŒ ์ƒ์„ฑ๋˜๋‚˜์š”?

๎™Œ
Bio-Techne Corp์˜ ๋ฆฌ์Šคํฌ ๊ด€๋ฆฌ ์ ์ˆ˜๋ฅผ ํ‰๊ฐ€ํ•˜๊ธฐ ์œ„ํ•ด์„œ๋Š” ์ˆ˜์ต, ๋ฆฌ์Šคํฌ, ๋ณ€๋™์„ฑ ๋ฐ ์œ ๋™์„ฑ๊ณผ ๊ด€๋ จ๋œ ๋‹ค์–‘ํ•œ ์ฃผ์š” ์ง€ํ‘œ๋ฅผ ๋ถ„์„ํ•ฉ๋‹ˆ๋‹ค.
์ผ์ผ ์ตœ๊ณ  ๋ฐ ์ตœ์ € ์ˆ˜์ต๋ฅ ์€ ์ž ์žฌ์ ์ธ ์ด์ต๊ณผ ์†์‹ค์˜ ๊ทœ๋ชจ๋ฅผ ๋ฐ˜์˜ํ•˜๋ฉฐ, ์ƒคํ”„ ๋น„์œจ์€ ๋ฆฌ์Šคํฌ๋ฅผ ์กฐ์ •ํ•œ ์ˆ˜์ต ์„ฑ๊ณผ๋ฅผ ์ธก์ •ํ•ฉ๋‹ˆ๋‹ค. ๋ฆฌ์Šคํฌ ์ธก๋ฉด์—์„œ๋Š” ์ตœ๋Œ€ ์†์‹คํญ๊ณผ ์ˆ˜์ต ๋Œ€๋น„ ์†์‹คํญ ๋น„์œจ์„ ๋ถ„์„ํ•˜์—ฌ ๊ทน๋‹จ์ ์ธ ์†์‹ค ์‹œ๋‚˜๋ฆฌ์˜ค๋ฅผ ํŒŒ์•…ํ•ฉ๋‹ˆ๋‹ค. ์™œ๋„๋Š” ์ˆ˜์ต ๋ถ„ํฌ์™€ ์„ฑ๊ณผ์˜ ํŽธํ–ฅ ์—ฌ๋ถ€๋ฅผ ํ‰๊ฐ€ํ•˜๋Š” ๋ฐ ๋„์›€์ด ๋ฉ๋‹ˆ๋‹ค. ์‹คํ˜„ ๋ณ€๋™์„ฑ, ํ‘œ์ค€ํ™”๋œ ์‹ค์งˆ๊ฐ€๊ฒฉ๋ณ€๋™ํญ๊ณผ ๊ฐ™์€ ๋ณ€๋™์„ฑ ์ง€ํ‘œ๋Š” ๊ฐ€๊ฒฉ ๋ณ€๋™์„ ๋ณด์—ฌ์ค๋‹ˆ๋‹ค. ํ•˜๋ฐฉ ๋ฆฌ์Šคํฌ๋ฅผ ์กฐ์ •ํ•œ ์ˆ˜์ต์€ ์ž ์žฌ์ ์ธ ์†์‹ค๊ณผ ์ด์ต์— ๋Œ€ํ•œ ์ธ์‚ฌ์ดํŠธ๋ฅผ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ๋งˆ์ง€๋ง‰์œผ๋กœ, ํ‰๊ท  ๊ฑฐ๋ž˜๋Œ€๊ธˆ ๋ฐ ๊ฑฐ๋ž˜๋Œ€๊ธˆ ํŽธ์ฐจ์™€ ๊ฐ™์€ ์œ ๋™์„ฑ ์ง€ํ‘œ๋Š” ํ•ด๋‹น ์ฃผ์‹์˜ ๊ฑฐ๋ž˜ ํ™œ๋ฐœ์„ฑ์„ ๋‚˜ํƒ€๋ƒ…๋‹ˆ๋‹ค.
์ด๋Ÿฌํ•œ ์ง€ํ‘œ๋ฅผ ์ข…ํ•ฉ์ ์œผ๋กœ ๋ถ„์„ํ•˜๋ฉด Bio-Techne Corp์˜ ๋ฆฌ์Šคํฌ-์ˆ˜์ต ํ”„๋กœํŒŒ์ผ์— ๋Œ€ํ•œ ๋‹ค์ฐจ์›์ ์ธ ์ดํ•ด๋ฅผ ์ œ๊ณตํ•˜๋ฉฐ, ์ด๋Š” ๋ฆฌ์Šคํฌ ๊ด€๋ฆฌ ์ ์ˆ˜์˜ ํ•ต์‹ฌ ์š”์†Œ๋กœ ์ž‘์šฉํ•ฉ๋‹ˆ๋‹ค. ์ ์ˆ˜๊ฐ€ ๋†’์„์ˆ˜๋ก Bio-Techne Corp์˜ ๋ฆฌ์Šคํฌ๊ฐ€ ๋‚ฎ๋‹ค๋Š” ๊ฒƒ์„ ์˜๋ฏธํ•ฉ๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ